Expanding medical therapies based on Crispr gene-editing globally is “unrealistic” and the sector needs heavy investment to make the technology, which could transform treatment of diseases, accessible to all, according to its co-discoverer.
Crispr基因编辑技术的共同发现者珍妮弗•道德纳(Jennifer Doudna)表示，在manbetx app苹果 推广基于Crispr基因编辑技术的医疗疗法是“不现实的”，该领域需要大量投资才能使这项可以改变疾病治疗的技术惠及所有人。
您已阅读5%（348字），剩余95%（6062字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。